Granulomonocytapheresis as a cell‐dependent treatment option for patients with inflammatory bowel disease: Concepts and clinical features for better therapeutic outcomes
Abbi R. Saniabadi(Otsuka (Japan)), Rodolfo Sacco, Wolfgang Kruis(ThyssenKrupp (Germany)), Tomotaka Tanaka(Kyoto University), Takayuki Yamamoto(Yokkaichi Social Insurance Hospital)
Cited by 26
Related Papers
European evidence-based Consensus on the management of ulcerative colitis: Current management
|Journal of Crohn s and Colitis|2008|558
Prevalence, Clinical Features, and Prognosis of Acute Myocardial Infarction Attributable to Coronary Artery Embolism
|Circulation|2015|401
Factors affecting recurrence after surgery for Crohn’s disease
|World Journal of Gastroenterology|2005|284
S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM)
|Zeitschrift für Gastroenterologie|2011|231
Post-stroke epilepsy
|Neurochemistry International|2017|163